Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China

To estimate the prevalence of extensively drug-resistant tuberculosis (XDR TB) in China, we retrospectively analyzed drug-resistance profiles of 989 clinical Mycobacterium tuberculosis isolates. We found 319 (32.3%) isolates resistant to >1 first-line drugs; 107 (10.8%) isolates were multidrug re...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yunfeng, Wang, Yan, Wang, Junling, Jing, Hui, Yu, Chunbao, Wang, Haiying, Liu, Zhimin, Graviss, Edward A., Ma, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2011
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165999/
https://www.ncbi.nlm.nih.gov/pubmed/21392442
http://dx.doi.org/10.3201/eid1703.100812
_version_ 1782211101905125376
author Deng, Yunfeng
Wang, Yan
Wang, Junling
Jing, Hui
Yu, Chunbao
Wang, Haiying
Liu, Zhimin
Graviss, Edward A.
Ma, Xin
author_facet Deng, Yunfeng
Wang, Yan
Wang, Junling
Jing, Hui
Yu, Chunbao
Wang, Haiying
Liu, Zhimin
Graviss, Edward A.
Ma, Xin
author_sort Deng, Yunfeng
collection PubMed
description To estimate the prevalence of extensively drug-resistant tuberculosis (XDR TB) in China, we retrospectively analyzed drug-resistance profiles of 989 clinical Mycobacterium tuberculosis isolates. We found 319 (32.3%) isolates resistant to >1 first-line drugs; 107 (10.8%) isolates were multidrug resistant, of which 20 (18.7%) were XDR. XDR TB is of major concern in China.
format Online
Article
Text
id pubmed-3165999
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-31659992011-11-15 Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China Deng, Yunfeng Wang, Yan Wang, Junling Jing, Hui Yu, Chunbao Wang, Haiying Liu, Zhimin Graviss, Edward A. Ma, Xin Emerg Infect Dis Dispatch To estimate the prevalence of extensively drug-resistant tuberculosis (XDR TB) in China, we retrospectively analyzed drug-resistance profiles of 989 clinical Mycobacterium tuberculosis isolates. We found 319 (32.3%) isolates resistant to >1 first-line drugs; 107 (10.8%) isolates were multidrug resistant, of which 20 (18.7%) were XDR. XDR TB is of major concern in China. Centers for Disease Control and Prevention 2011-03 /pmc/articles/PMC3165999/ /pubmed/21392442 http://dx.doi.org/10.3201/eid1703.100812 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Deng, Yunfeng
Wang, Yan
Wang, Junling
Jing, Hui
Yu, Chunbao
Wang, Haiying
Liu, Zhimin
Graviss, Edward A.
Ma, Xin
Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China
title Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China
title_full Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China
title_fullStr Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China
title_full_unstemmed Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China
title_short Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China
title_sort laboratory-based surveillance of extensively drug-resistant tuberculosis, china
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165999/
https://www.ncbi.nlm.nih.gov/pubmed/21392442
http://dx.doi.org/10.3201/eid1703.100812
work_keys_str_mv AT dengyunfeng laboratorybasedsurveillanceofextensivelydrugresistanttuberculosischina
AT wangyan laboratorybasedsurveillanceofextensivelydrugresistanttuberculosischina
AT wangjunling laboratorybasedsurveillanceofextensivelydrugresistanttuberculosischina
AT jinghui laboratorybasedsurveillanceofextensivelydrugresistanttuberculosischina
AT yuchunbao laboratorybasedsurveillanceofextensivelydrugresistanttuberculosischina
AT wanghaiying laboratorybasedsurveillanceofextensivelydrugresistanttuberculosischina
AT liuzhimin laboratorybasedsurveillanceofextensivelydrugresistanttuberculosischina
AT gravissedwarda laboratorybasedsurveillanceofextensivelydrugresistanttuberculosischina
AT maxin laboratorybasedsurveillanceofextensivelydrugresistanttuberculosischina

Ejemplares similares